AUD 17/12/09 19.00-23.00 (next 4 hours)0.8986 Target0.8963 Buy0.8935 Critical Resistance0.8901 Critical Support0.8873 Sell0.8850 Target
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%